Abingworth LLP Buys Phathom Pharmaceuticals Inc, Soleno Therapeutics Inc, Protara Therapeutics Inc, Sells Sierra Oncology Inc, Chiasma Inc

London, X0, based Investment company

Abingworth LLP (Current Portfolio) buys Phathom Pharmaceuticals Inc, Soleno Therapeutics Inc, Protara Therapeutics Inc, sells Sierra Oncology Inc, Chiasma Inc during the 3-months ended 2020Q2, according to the most recent filings of the investment company, Abingworth LLP. As of 2020Q2, Abingworth LLP owns 13 stocks with a total value of $216 million. These are the details of the buys and sells.

• New Purchases: PHAT, TARA,
• Added Positions: SLNO,
• Sold Out: SRRA, CHMA,

For the details of Abingworth LLP's stock buys and sells, go to https://www.gurufocus.com/guru/abingworth+llp/current-portfolio/portfolio

These are the top 5 holdings of Abingworth LLP

1. Personalis Inc (PSNL) - 5,449,294 shares, 32.76% of the total portfolio.
2. Phathom Pharmaceuticals Inc (PHAT) - 1,203,135 shares, 18.26% of the total portfolio. New Position
3. CRISPR Therapeutics AG (CRSP) - 519,198 shares, 17.65% of the total portfolio.
4. Soleno Therapeutics Inc (SLNO) - 10,302,602 shares, 10.56% of the total portfolio. Shares added by 47.83%
5. Exicure Inc (XCUR) - 6,977,000 shares, 7.86% of the total portfolio.

New Purchase: Phathom Pharmaceuticals Inc (PHAT)

Abingworth LLP initiated holding in Phathom Pharmaceuticals Inc. The purchase prices were between $25.06 and $54.6, with an estimated average price of $38.17. The stock is now traded at around $40.19. The impact to a portfolio due to this purchase was 18.26%. The holding were 1,203,135 shares as of .

New Purchase: Protara Therapeutics Inc (TARA)

Abingworth LLP initiated holding in Protara Therapeutics Inc. The purchase prices were between $22 and $60.7, with an estimated average price of $30.86. The stock is now traded at around $24.52. The impact to a portfolio due to this purchase was 1.39%. The holding were 53,612 shares as of .

Added: Soleno Therapeutics Inc (SLNO)

Abingworth LLP added to a holding in Soleno Therapeutics Inc by 47.83%. The purchase prices were between $1.77 and $4.23, with an estimated average price of $2.9. The stock is now traded at around $1.99. The impact to a portfolio due to this purchase was 3.42%. The holding were 10,302,602 shares as of .

Sold Out: Sierra Oncology Inc (SRRA)

Abingworth LLP sold out a holding in Sierra Oncology Inc. The sale prices were between $8.88 and $15.31, with an estimated average price of $12.34.

Sold Out: Chiasma Inc (CHMA)

Abingworth LLP sold out a holding in Chiasma Inc. The sale prices were between $3.39 and $7.04, with an estimated average price of $5.47.

Here is the complete portfolio of Abingworth LLP. Also check out:

1. Abingworth LLP's Undervalued Stocks
2. Abingworth LLP's Top Growth Companies, and
3. Abingworth LLP's High Yield stocks
4. Stocks that Abingworth LLP keeps buying